Efficacy of linezolid against Panton-Valentine leukocidin (PVL)-positive meticillin-resistant Staphylococcus aureus (MRSA) in a mouse model of haematogenous pulmonary infection

International Journal of Antimicrobial Agents

Volumn 34, Issue 5, 2009, Pages 477-481

  Yanagihara, Katsunori ^a   Kihara, Rie ^a   Araki, Nobuko ^a   Morinaga, Yoshitomo ^a   Seki, Masafumi ^a   Izumikawa, Koichi ^a   Kakeya, Hiroshi ^a   Yamamoto, Yoshihiro ^a   Yamada, Yasuaki ^a   Kohno, Shigeru ^a   Tsukamoto, Kazuhiro ^a   Kamihira, Shimeru ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Linezolid; MRSA; Pathogenesis; Resistant bacteria

Indexed keywords

INTERLEUKIN 1BETA; LINEZOLID; MACROPHAGE INFLAMMATORY PROTEIN 2; PANTON VALENTINE LEUKOCIDIN; TUMOR NECROSIS FACTOR ALPHA; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BACTERIAL PNEUMONIA; CONTROLLED STUDY; DRUG EFFICACY; HEMATOGENOUS PNEUMONIA; HISTOPATHOLOGY; INFLAMMATION; LUNG ABSCESS; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE;

ACETAMIDES; ANIMALS; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL TOXINS; COLONY COUNT, MICROBIAL; CYTOKINES; EXOTOXINS; HISTOCYTOCHEMISTRY; LEUKOCIDINS; LUNG; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; OXAZOLIDINONES; PNEUMONIA, STAPHYLOCOCCAL; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VIRULENCE FACTORS;

EID: 69949113168     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.06.024     Document Type: Article

References (14)

1. Herold B.C., Immergluck L.C., Maranan M.C., Lauderdale D.S., Gaskin R.E., Boyle-Vavra S., et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no predisposing risk. JAMA 279 (1997) 593-598
2. Boyle-Vavra S., and Daum R.S. Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin. Lab Invest 87 (2007) 3-9
3. Vandenesch F., Naimi T., Enright M.C., Lina G., Nimmo G.R., Heffernan H., et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 9 (2003) 978-984
4. Gillet Y., Issartel B., Vanhems P., Fournet J.C., Lina G., Bes M., et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359 (2002) 753-759
5. Genestier A.L., Michallet M.C., Prévost G., Bellot G., Chalabreysse L., Peyrol S., et al. Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils. J Clin Invest 115 (2005) 3117-3127
6. Takizawa Y., Taneike I., Nakagawa S., Oishi T., Nitahara Y., Iwakura N., et al. A Panton-Valentine leucocidin (PVL)-positive community-acquired methicillin-resistant Staphylococcus aureus (MRSA) strain, another such strain carrying a multiple-drug resistance plasmid, and other more-typical PVL-negative MRSA strains found in Japan. J Clin Microbiol 43 (2005) 3356-3363
7. Lina G., Piémont Y., Godail-Gamot F., Bes M., Peter M.O., Gauduchon V., et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29 (1999) 1128-1132
8. Kohno S., Yamaguchi K., Aikawa N., Sumiyama Y., Odagiri S., Aoki N., et al. Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan. J Antimicrob Chemother 60 (2007) 1361-1369
9. Yanagihara K., Kaneko Y., Sawai T., Miyazaki Y., Tsukamoto K., Hirakata Y., et al. Efficacy of linezolid against methicillin-resistant or vancomycin-insensitive Staphylococcus aureus in a model of hematogenous pulmonary infection. Antimicrob Agents Chemother 46 (2002) 3288-3291
10. Sawai T., Tomono K., Yanagihara K., Yamamoto Y., Kaku M., Hirakata Y., et al. Role of coagulase in a murine model of hematogenous pulmonary infection induced by intravenous injection of Staphylococcus aureus enmeshed in agar beads. Infect Immun 65 (1997) 466-471
11. Yanagihara K., Seki M., Izumikawa K., Higashiyama Y., Miyazaki Y., Hirakata Y., et al. Potency of DX-619, a novel des-F(6)-quinolone, in haematogenous murine bronchopneumonia caused by methicillin-resistant and vancomycin-intermediate Staphylococcus aureus. Int J Antimicrob Agents 28 (2006) 212-216
12. Stevens D.L., Ma Y., Salmi D.B., McIndoo E., Wallace R.J., and Bryant A.E. Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Infect Dis 195 (2007) 202-211
13. Dumitrescu O., Boisset S., Badiou C., Bes M., Benito Y., Reverdy M.E., et al. Effect of antibiotics on Staphylococcus aureus producing Panton-Valentine leukocidin. Antimicrob Agents Chemother 51 (2007) 1515-1519
14. Bernardo K., Pakulat N., Fleer S., Schnaith A., Utermöhlen O., Krut O., et al. Subinhibitory concentrations of linezolid reduce Staphylococcus aureus virulence factor expression. Antimicrob Agents Chemother 48 (2004) 546-555